Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Galapagos
Pharma
FDA signs off on first engineered cell therapy for a solid tumor
Adaptimmune has won FDA approval for its synovial sarcoma treatment Tecelra, the first engineered cell therapy for a solid tumor.
Kevin Dunleavy
Aug 2, 2024 8:56am
Galapagos bolsters decentralized CAR-T manufacturing
May 15, 2024 5:33pm
Galapagos sells its Jyseleca business to Italy's Alfasigma
Oct 31, 2023 9:10am
Galapagos slashes Jyseleca sales projection, scraps submissions
Aug 4, 2023 11:12am
Galapagos' Jyseleca can't prove its worth in Crohn's disease
Feb 9, 2023 11:36am
'The Top Line' podcast: Alzheimer's moonshot, diversity and more
Jun 24, 2022 6:00am
